GCM
OACC

Ghisallo Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Ghisallo Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.82M Hold
450,000
– – 0.09% 160
2026
Q1 		$4.78M Hold
450,000
– – 0.13% 125
2025
Q4 		$4.78M Hold
450,000
– – 0.21% 95
2025
Q3 		$4.71M Hold
450,000
– – 0.15% 125
2025
Q2 		$4.72M Hold
450,000
– – 0.13% 117
2025
Q1 		$4.59M Buy
+450,000
New +$4.52M 0.4% 58

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ghisallo Capital Management's OACC Position: Q2 2026 in Review

Ghisallo Capital Management held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 450,000 shares worth $4.82M. The position accounts for 0.09% of the portfolio, ranked #160.

Ghisallo Capital Management first reported a position in OACC in Q1 2025 and has held it in 6 quarters since. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Ghisallo Capital Management held 450,000 shares of Oaktree Acquisition Corp III Life Sciences worth $4.82M as of Q2 2026.
  • Ghisallo Capital Management left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.09% of Ghisallo Capital Management's portfolio in Q2 2026, its #160 holding.
  • Ghisallo Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.